CBP: Hermitage Capital’s Browder has right to enter USWorld October 24, 3:56
US doesn't allow Russia to remove archive from Consulate General in San FranciscoRussian Politics & Diplomacy October 24, 1:20
Trump potentially ready to meet with Putin at APEC summitWorld October 23, 20:44
Mancini unlikely to drop Russia’s Zenit for West Ham — Italian ex-striker VialliSport October 23, 20:05
Volkswagen and Daimler inspected in European Commission’s antimonopoly probesBusiness & Economy October 23, 19:40
Baltic Fleet corvettes on long-distance voyage pass through English ChannelMilitary & Defense October 23, 18:56
South Korean chain to open 33 movie theaters in MoscowBusiness & Economy October 23, 18:41
Russian MP blasts Riga’s educational language reform ploy as ‘linguistic genocide’World October 23, 18:28
Collector robbed of masterpieces by top Russian artists worth over half a million dollarsSociety & Culture October 23, 18:04
MOSCOW, October 3. /TASS/. Russia’s Federal Antimonopoly Service (FAS) may open an antimonopoly probe against B. Braun Medical, the Russian subsidiary of Germany’s B. Braun, press service of the authority told TASS on Tuesday.
"Inspection of B. Braun Medical was completed. Opening of the antimonopoly probe is under consideration now. Inspections of Pharmstandard and Biocad have not been completed yet," the press service said.
B. Braun Medical is suspected of participating in one of the largest cartel agreements in pharmaceuticals trading. It is estimated as totaling over 10 bln rubles ($172.8 mln) and covers drugs of various categories, FAS department head of Andrei Tenishev told TASS earlier in June.
It was reported earlier Russian antimonopoly watchdog found over 70 price fixings during procurement of drugs and medical products as of 2016 year-end.